Related Experiment Video
Updated: Aug 19, 2026

Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018
Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection
Darius M Moshfeghi1, Peter K Kaiser, Sophie J Bakri
1Department of Ophthalmology, Stanford University Stanford, California, USA.
Background And Objective:
To report acute postoperative, presumed sterile endophthalmitis following intravitreal injection of triamcinolone acetonide (IVTA).
Patients And Methods:
Retrospective, interventional, multicenter study of patients with acute sterile endophthalmitis following IVTA injection.
Results:
A total of 922 IVTA injections were performed. Eight eyes of 8 patients with presumed sterile endophthalmitis were identified. The incidence of endophthalmitis was 0.87% (95% confidence interval, 0.38% to 1.70%). Median time to presentation was 1.5 days (range, 1 to 7 days). Median presenting visual acuity was 20/563 (range, 20/80 to light perception). Initial treatment included vitreous tap and injection of antibiotics (n = 4), pars plana vitrectomy and injection of intravitreal antibiotics (n = 2), or systemic treatment alone with oral levofloxacin (n = 2). Six of 6 intraocular cultures were sterile. Median follow-up was 5.9 months (range, 4 to 9 months) with a median visual acuity at last follow-up of 20/75 (range, 20/40 to counting fingers).
Conclusions:
Acute presumed sterile endophthalmitis following IVTA injection presents early in the postoperative period. Visual outcomes are generally good.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Glaucoma: Overview